<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Biomedical Journal</title>
<title_fa>مجله بیومدیکال ایران</title_fa>
<short_title>IBJ</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ibj.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1028-852X</journal_id_issn>
<journal_id_issn_online>2008-823X</journal_id_issn_online>
<journal_id_pii>-</journal_id_pii>
<journal_id_doi>10.61882/ibj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>-</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>-</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1377</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>1998</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>2</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluation of (5R,6R)-5-Bromo-6-Ethoxy-5-Ethyl-5,6-Dihydro-2&#039;- Deoxyuridine as a Brain-Targeted Prodrug of 5-Ethyl-2&#039;- Deoxyuridine</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa>مقاله کامل</content_type_fa>
	<content_type>Full Length/Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>(+)-Trans-(5R,6R)-5-bromo-6-ethoxy-5-ethyl-5,6-dihydro-2&amp;#39;-deoxyuridine [(5R,6R)-BEEDU], a po&#8204;tential brain-targeted prodrug of 5-ethyl-2&amp;#39;-deoxyuridine (EDU), was synthesized by the regiospecific addition of BrOEt to the 5,6-olefinic bond of EDU. (5R,6R)-BEEDU is more lipophilic (log P = 0.04) than EDU (log P = -1.09). In vitro incubation of (5R,6R)-BEEDU with rat whole blood and brain ho&#8204;mogenate resulted in a 53% and 16% conversion, respectively, to EDU. In contrast, (5R,6R)-BEEDU was not converted to EDU upon incubation with glutathione (GSH) at 37&amp;deg;C for 36 hours. After i.v. injection into rats, (5R,6R)-BEEDU was rapidly converted to EDU, which was then further metabo&#8204;lized like EDU. However, (5R,6R)-BEEDU provided a substantially higher Ryncentration of EDU in blood, relative to that when EDU was injected. A biodistribution study of [4- C]-(5R,6R)-BEEDU in Balb/c mice showed that (5R,6R)-BEEDU provided significantly higher (P &lt; 0.05) radirctivityievels in brain samples at 8, 18 and 30 min post injection than observfid after injection of [4- C]-EDU. The higher repioactivity levels in liver samples after injection of [4- C]-(5R,6R)-BEEDU, relative to those after [4- C]-EDU, indicates that the 5,6-dihydro derivative undergoes a higher hepatic extraition than EDU. Clearance of radioactivity from blood qv&amp;#39; excretion into urine, after injection of [4 C]&#8204;EDU, was much faster than that after injection of [4- C]-(5R,6R)-BEEDU.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>5-Ethyl-2-deoxyuridine, Dihydro prodrugs, Herpes Simplex Virus, Brain-targeted</keyword>
	<start_page>105</start_page>
	<end_page>113</end_page>
	<web_url>http://ibj.pasteur.ac.ir/browse.php?a_code=A-10-1-430&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Majid</first_name>
	<middle_name></middle_name>
	<last_name>Cheraghali</last_name>
	<suffix></suffix>
	<first_name_fa>مجید</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>چراغعلی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Rakesh</first_name>
	<middle_name></middle_name>
	<last_name>Kumar</last_name>
	<suffix></suffix>
	<first_name_fa>Leonard I.</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Wiebe</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Kevin W.</first_name>
	<middle_name></middle_name>
	<last_name>Morin</last_name>
	<suffix></suffix>
	<first_name_fa>Edward E.</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Knaus</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Edward E.</first_name>
	<middle_name></middle_name>
	<last_name>Knaus</last_name>
	<suffix></suffix>
	<first_name_fa>Kevin W.</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Morin</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Leonard I.</first_name>
	<middle_name></middle_name>
	<last_name>Wiebe</last_name>
	<suffix></suffix>
	<first_name_fa>Rakesh</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Kumar</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
